Discovery of a Uracil-Derived Small Organic Ligand with Cytotoxic Effect on Human PC-3 Cell Lines via Apoptosis
dc.contributor.author | Poslu, Ayse Halic | |
dc.contributor.author | Balaban, Rumeysa | |
dc.contributor.author | Nalbantsoy, Ayse | |
dc.contributor.author | Ertik, Onur | |
dc.contributor.author | Cecener, Gulsah | |
dc.contributor.author | Koz, Omer | |
dc.contributor.author | Koz, Gamze | |
dc.date.accessioned | 2025-05-08T12:59:12Z | |
dc.date.available | 2025-05-08T12:59:12Z | |
dc.date.issued | 2024 | |
dc.department | Ege Üniversitesi, Mühendislik Fakültesi, Biyomühendislik Bölümü | |
dc.description.abstract | A series of novel 6-amino-5-salicylidene uracils (1-19) were efficiently synthesized from the condensation reaction of 5,6-diamino-1,3-dimethyluracil with substituted salicylaldehydes. The structural characterization of the compounds was performed with spectroscopic methods and elemental analysis. All compounds were evaluated for their in vitro cytotoxic activity against PC-3 (human prostate adenocarcinoma), A549 (human alveolar adenocarcinoma) and SHSY-5Y (human neuroblastoma) cancer cell lines. 3,5-di-tert-Butylsalicylaldehyde derived salicylideneuracil (6ASU-8) showed promising cytotoxic activity against PC-3 cells with an IC50 value of 1.53 +/- 1.01 mu M, compared to doxorubicin, which had an IC50 value of 3.77 +/- 1.34 mu M. 6ASU-8 induced cell cycle arrest at the G2/M phase and promoted apoptosis in PC-3 cells (p<0.05*). Molecular docking results supported the experimental data, indicating that 6ASU-8 is more effective than doxorubicin. Additionally, in silico ADME analysis revealed that 6ASU-8 possesses acceptable predictive physicochemical properties. | |
dc.identifier.citation | Poslu, A. H., Balaban, R., Nalbantsoy, A., Ertik, O., Çeçener, G., Koz, Ö., & Koz, G. (2024). Discovery of a Uracil‐Derived small organic ligand with cytotoxic effect on human PC‐3 cell lines via apoptosis. ChemistrySelect (Weinheim), 9(36), n/a. | |
dc.identifier.doi | 10.1002/slct.202403713 | |
dc.identifier.endpage | 9 | |
dc.identifier.issn | 23656549 | |
dc.identifier.issue | 36 | |
dc.identifier.scopus | 2-s2.0-8520472413 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 1 | |
dc.identifier.uri | https://doi.org/10.1002/slct.202403713 | |
dc.identifier.uri | https://hdl.handle.net/11454/117223 | |
dc.identifier.volume | 9 | |
dc.identifier.wos | WOS:001318769800001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.institutionauthor | Nalbantsoy, Ayse | |
dc.language.iso | en | |
dc.publisher | Wiley - VCH Verlag Gmbh | |
dc.relation.ispartof | ChemistrySelect | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Apoptosis | |
dc.subject | Cytotoxicity | |
dc.subject | Molecular docking | |
dc.subject | PC-3 | |
dc.subject | Uracil | |
dc.title | Discovery of a Uracil-Derived Small Organic Ligand with Cytotoxic Effect on Human PC-3 Cell Lines via Apoptosis | |
dc.type | Article |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.17 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: